Emergent BioSolutions Receives FDA Approval for Expanded NARCAN Nasal Spray Multipack Options.

Emergent BioSolutions receives FDA approval for NARCAN Nasal Spray multipacks, expanding the product suite to include 6-count and 24-count multipack options. This approval aims to improve cost-effectiveness and accessibility of the life-saving medication, particularly for organizations operating large-scale distribution programs. The new formats offer enhanced flexibility and distribution efficiency.